Similar Jobs
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
As the Madrigal expands commercial activities globally, the company is seeking a Chief Accounting Officer (CAO), who will be a close strategic partner to the CFO and responsible for leading all aspects of accounting operations and reporting. The CAO will oversee financial reporting, technical accounting, internal controls, tax, treasury and payroll. The CAO, along with the CFO, will lead the Audit Committee of the Board of Directors and manage the relationship with auditors. The ideal candidate brings deep expertise in U.S. GAAP, SEC reporting, and Sarbanes-Oxley (SOX) compliance, particularly within commercial-stage or publicly traded life sciences companies.
Areas of specific key responsibilities will include:
Leading and managing the accounting organization, including general ledger, revenue recognition, accounts payable/receivable, payroll, and financial consolidations.
Ensuring timely and accurate preparation of monthly, quarterly, and annual financial statements in accordance with U.S. GAAP and SEC requirements.
Overseeing preparation and filing of 10-Qs, 10-Ks, and other periodic SEC filings, including the proxy, in partnership with legal and investor relations teams.
Implementing and maintaining robust internal controls over financial reporting in accordance with SOX 404.
Partnering with Commercial, R&D, Supply Chain, and FP&A teams to ensure accurate and compliant accounting treatment for revenue, inventory, COGS, and other commercial-stage activities.
Leading implementation of new ERP and financial systems globally
Managing external audit relationships and leading the annual audit process and quarterly reviews.
Leading technical accounting research and documentation for complex transactions (e.g., revenue contracts, licensing, M&A, equity and/or financing, and collaborations).
Overseeing tax strategy and compliance, including transfer pricing and global tax reporting.
Monitoring and implementing accounting standards and regulatory developments, assessing and communicating business impacts.
Mentoring and developing the accounting team, fostering a culture of collaboration, accountability, excellence, and continuous improvement.
PROFESSIONAL EXPERIENCE/QUALIFICATIONS
15+ years of progressive accounting and finance experience, with 5+ years experience in a leadership role at a commercial-stage biotech or pharmaceutical company.
Deep knowledge of U.S. GAAP, SEC reporting, and SOX compliance.
Experience managing a global accounting function in a fast-paced, dynamic environment.
Strong leadership, interpersonal, and communication skills with the ability to influence across functions.
Experience working with ERP systems (e.g., NetSuite) and financial reporting tools.
Prior Big 4 public accounting experience.
EDUCATION
Bachelor’s degree in Accounting, Finance, or related field; CPA required.
Compensation: Base salary is determined by several factors that include, but are not limited to, a successful candidate's qualifications, skills, education, experience, business needs, and market demands. The role may also be eligible for bonus, equity, and comprehensive benefits, which include flexible paid time off (PTO), medical, dental, vision, and life and disability insurance.
Madrigal is an Equal Opportunity Employer. All employment is decided on the basis of qualifications, merit, and business need. Applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected by applicable federal, state, or local law.
Unsolicited resumes from agencies should not be forwarded to Madrigal. Madrigal will not be responsible for any fees arising from the use of resumes through this source. Madrigal will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established.
Please be aware that we are currently receiving numerous reports of individuals misrepresenting themselves as Madrigal Pharmaceuticals’ Hiring Managers, seeking to engage with job candidates through fraudulent online advertisements or job posting sites. These unauthorized individuals are using Madrigal’s name and logo in an attempt to solicit up-front fees and obtain personal information from interested job candidates. Please know that Madrigal does not conduct interviews via text or in chat rooms; conduct interviews via Skype, RingCentral or solely via telephone; charge candidates an advance fee of any kind (e.g., fees for purchasing equipment); nor does it offer positions of employment without undergoing a thorough recruiting process. Interviews with Madrigal are conducted via the Zoom platform.
Please also note that any correspondence with regard to employment would come from an authorized madrigalpharma.com email address or from an email address from one of our trusted search firm partners. We are aware that incorrect/fraudulent email addresses, with Madrigal misspelled, have been utilized in these most recent fraud attempts. If you receive unsolicited employment offers from people claiming to work for Madrigal we recommend that you: do not respond to their questions; do not open any attachments; and do not click on any hyperlinks.
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories